Skip to main content
. 2019 Jan 10;14(1):e0210413. doi: 10.1371/journal.pone.0210413

Table 5. Pathologic and oncologic outcomes.

Variables Median (interquartile range) or counts (%) P
OPN (N = 64) RPN (N = 85)
Tumor size (cm) 3.1 (2.3–4.8) 4.3 (2.9–5.2) 0.014
Pathological stage 4 (6.3%) 1 (1.2%) 0.165
    pT1 57 (89.1%) 74 (87.1%)
    pT2 3 (4.7%) 10 (11.8%)
    pT3 4 (6.3%) 1 (1.2%)
Fuhrmann grade 0.386
    ≤ 2 36 (56.3%) 40 (47.1%)
    ≥ 3 28 (43.8%) 45 (52.9%)
Histological subtype 0.203
    Clear cell 50 (78.1%) 65 (76.5%)
    Papillary 3 (4.7%) 1 (1.2%)
    Chromophobe 3 (4.7%) 10 (11.8%)
    Collecting duct 0 (0%) 0 (0%)
    Unclassified 0 (0%) 2 (2.4%)
    Benign 8 (12.5%) 7 (8.2%)
Positive surgical margin 1 (1.6%) 0 (0%) 0.432
Recurrence 2 (3.1%) 4 (4.7%) 0.306
Overall mortality 3 (4.7%) 0 (0%) 0.077
Follow-up duration, months 53.0 (33.3–81.0) 15.0 (5.5–33.0) <0.001

OPN, open partial nephrectomy; RPN, robotic partial nephrectomy